Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
12,050 GBX | -0.87% | +0.52% | +13.68% |
10:23am | Cellectis Secures $140 Million Additional Equity Investment From AstraZeneca | MT |
09:59am | AstraZeneca: equity investment in Cellectis | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.68% | 234B | |
+26.08% | 662B | |
+20.58% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 289B | |
+4.12% | 198B | |
-10.51% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca's Biliary Tract Cancer Combo Cuts Death Risk in Late-Stage Trial